OncoSec Releases Devices for Use in Clinical Trials

After establishing engineering and manufacturing capabilities, transferring and updating regulatory, design, and manufacturing documentation, and implementing a new quality assurance system, the OncoSec Medical System (OMS) devices are released for shipment to clinical sites in time for the upcoming OMS clinical trials.

The company now has inventory of OMS investigational devices adequate to support known and anticipated clinical study requirements well into 2013.